Milwaukee-based PROMISS Diagnostics raises $400,000

Funding round led by Wisconsin Alumni Research Foundation

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin.

PROMISS Diagnostics, Inc., a Milwaukee-based company developing an early-detection ovarian cancer test, has raised $400,000 in a seed round of funding, the company announced Friday. The funding round was led by the Wisconsin Alumni Research Foundation with additional investments from Cream City Venture Capital, Northwestern Mutual’s $5 million venture fund. PROMISS Diagnostics is a venture-stage

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now

What's New

BizPeople

Sponsored Content

Summer flash sale! Unlock all of BizTimes for just $7 / month

Limited time offer. New subscribers only.

Close the CTA

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.